NCT04008810View on ClinicalTrials.gov

Serum Neutrophil Gelatinase-associated Lipocalins (NGAL) and Chronic Kidney Disease

CompletedOBSERVATIONAL

Enrollment

1,032

Participants

Timeline

Start Date

October 3, 2019

Primary Completion Date

January 10, 2023

Study Completion Date

June 3, 2024

Conditions

Chronic Kidney DiseasesCKDNGALNeutrophil Gelatinase-associated LipocalinEmergency DepartmentAKIAcute Kidney Injury

Trial Locations (1)

Unknown

North Zealand Hospital, Hillerød

Sponsors

Collaborators (1)

BioPorto Diagnostics

All Listed Sponsors

collaborator

BioPorto Diagnostics

INDUSTRY

lead

Hillerod Hospital, Denmark

OTHER

NCT04008810 - Serum Neutrophil Gelatinase-associated Lipocalins (NGAL) and Chronic Kidney Disease | Biotech Hunter | Biotech Hunter